Eli Lilly expects to miss mark in fourth quarter

Article Abstract:

Eli Lilly and Co. is forecasting lower-than-expected results for the 2001 fourth-quarter. The company, which has been hurt by the sales decline in its antidepressant drug, also forecasted low results for the fiscal 2001 and 2002 periods.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Bristol-Myers earnings rise on strong U.S. sales

Article Abstract:

Bristol-Myers Squibb Co. posted strong earnings for the 1999 fourth-quarter. The company's earnings per diluted share increased more than one-and-a-half times from 20 cents in 1998 to 52 cents in 1999.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Bristol-Myers says net increased 11%, meeting estimates

Article Abstract:

Bristol-Myers Squibb Co. posted an increase of 11% in their net income for the 2000 fourth-quarter. The company posted $1.16 billion (1.23 billion euros) in net income for the period.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: